Bio-Works Technologies
Bio-Works Receives SEK 5.5 Million Order from Global Pharmaceutical Company
The customer, who has previously used WorkBeads affimAb in several commercial processes, has placed this repeat order as a strong sign of continued confidence in Bio-Works’ products. The order reinforces the ongoing collaboration between the two companies and lays the foundation for a deeper long-term partnership.
WorkBeads affimAb is designed for efficient and selective purification of antibodies and is a highly attractive solution for industrial-scale biopharmaceutical production.
“Receiving a repeat order from a global pharmaceutical leader is a clear validation of our products’ performance in demanding, large-scale processes. It confirms our strategy to be an innovative and trusted partner in biopharmaceutical manufacturing,” says Lone Carlbom, CEO of Bio-Works Technologies AB.
This order reflects Bio-Works’ continued growth and strengthens the company’s position as a strategic supplier to the global biopharmaceutical industry.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 11-07-2025 15:28 CET.
| Datum | 2025-07-11, kl 15:28 |
| Källa | Cision |
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.